Cascade of immune mechanism and consequences of inflammatory disorders
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Inflammatory responses arise as an outcome of tissues or organs exposure towards harmful stimuli like injury, toxic chemicals or pathogenic microorganism. It is a complex cascade of immune mechanism to overcome from tissue injury and to initiate the healing process by recruiting various immune cells, chemical mediators such as the vasoactive peptides and amines, pro-inflammatory cytokines, eicosanoids and acute-phase proteins to prevent tissue damage and ultimately complete restoration of the tissue function. The cytokines exhibits a central function in communication between the cells, inflammatory response initiation, amplification and their regulation. This review covers the importance of inflammatory responses; the significance of cytokines in inflammation and numerous inflammatory disorders/ailments due to the abrupt expression of cytokines and the hyper-inflammatory response or cytokine storm associated with poor prognosis in COVID-19 pandemic. Also highlighting the importance of naturally derived anti-inflammatory metabolites to overcome the side-effects of currently prevailing anti-inflammatory drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Free radicals in biology and medicine
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
Cytokines, Inflammation, and Pain
Zhang, J.-M., & An, J. (2007) · International Anesthesiology Clinics · doi:10.1097/aia.0b013e318034194e · Cited by 2,945
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · cited 1×
“TNF-α triggers the lipid mediators on vascular epithelial cell expression promoting oedema as well as eliciting immune cell infiltration by activating leukocyte adhesion molecules (Bradley, 2008).”
BackgroundDinarello, C. A. (2000) · Chest · doi:10.1378/chest.118.2.503 · Cited by 2,045
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Moore, K. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.165 · Cited by 1,884
Inflammation 2010: New Adventures of an Old Flame
Medzhitov, R. (2010) · Cell · doi:10.1016/j.cell.2010.03.006 · Cited by 1,834
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis
Wojdasiewicz, P., Poniatowski, Ł. A., & Szukiewicz, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/561459 · Cited by 1,608
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,352
Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,325
CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES
Arai, K.-I., Lee, F., Miyajima, A., Miyatake, S., Arai, N., & Yokota, T. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.004031 · Cited by 1,318
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
Kaminska, B. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.017 · Cited by 1,285
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Experimental models of inflammatory bowel disease
Elson, C. O., Sartor, R. B., Tennyson, G. S., & Riddell, R. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90599-5 · Cited by 1,212
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,131
Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation
Ferrero-Miliani, L., Nielsen, O. H., Andersen, P. S., & Girardin, S. E. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03261.x · Cited by 1,079
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Tedgård, U., Cowen, E. W., Pham, T.-H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 987
Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., & Romagnani, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.353 · Cited by 927
Historical insights into cytokines
Dinarello, C. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737772 · Cited by 926 · cited 2×
“IFN-α another cytokine involved in response to viral infections and are preferred to patients suffering with hepatitis B, and C and for the treatment of multiple sclerosis IFN-β for is effective (Dinarello, 2007).”
SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography
Klein, S., Cortese, M., Winter, S. L., Wachsmuth-Melm, M., Neufeldt, C. J., Cerikan, B., Stanifer, M. L., Boulant, S., Bartenschlager, R., & Chlanda, P. (2020) · Nature Communications · doi:10.1038/s41467-020-19619-7 · Cited by 731
Handbook of Mucosal Immunology
(1994) · Elsevier eBooks · doi:10.1016/c2009-1-03796-4 · Cited by 706
Alkaloid Biosynthesis: Metabolism and Trafficking
Ziegler, J., & Facchini, P. J. (2008) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.59.032607.092730 · Cited by 701
A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits
Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C.-Y., Gately, M. K., & Gubler, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14002 · Cited by 689
Cytokines and cognition–the case for a head-to-toe inflammatory paradigm.
Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50619.x · Cited by 637
NALP1 in Vitiligo-Associated Multiple Autoimmune Disease
Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., Fain, P. R., & Spritz, R. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061592 · Cited by 630
Characterization of tumor necrosis factor-deficient mice
Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8093 · Cited by 622
Oxidative Stress: Concept and Some Practical Aspects
Sies, H. (2020) · Antioxidants · doi:10.3390/antiox9090852 · Cited by 619
TNF receptor subtype signalling: Differences and cellular consequences
MacEwan, D. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00262-5 · Cited by 610 · cited 1×
“It is of greater significance that the appropriate level of TNF- α is beneficial for maintaining the key homeostatic functions of normal cells like cell proliferation, necrosis and apoptosis (MacEwan, 2002).”
BackgroundInflammatory Mechanisms: The Molecular Basis of Inflammation and Disease
Libby, P. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00352.x · Cited by 596
Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
Sartor, R. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90614-9 · Cited by 584
The biology of IL-12: coordinating innate and adaptive immune responses
Watford, W. T., Moriguchi, M., Morinobu, A., & O’Shea, J. J. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00043-1 · Cited by 576
Breaching multiple barriers: leukocyte motility through venular walls and the interstitium
Nourshargh, S., Hordijk, P. L., & Sixt, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2889 · Cited by 565
Inflammatory mechanisms: the molecular basis of inflammation and disease
Libby, P. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.dec.s140-s146 · Cited by 560
Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH2-terminal Kinases
Lo, Y. Y. C., Wong, J. M. S., & Cruz, T. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15703 · Cited by 497
Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 489
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
Wiemann, B., & Starnes, C. O. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90023-x · Cited by 467
Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease
Sparks Stein, P., Steffen, M. J., Smith, C., Jicha, G., Ebersole, J. L., Abner, E., & Dawson, D. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.04.006 · Cited by 463
HULL, K. M., DREWE, E., AKSENTIJEVICH, I., SINGH, H. K., WONG, K., MCDERMOTT, E. M., DEAN, J., POWELL, R. J., & KASTNER, D. L. (2002) · Medicine · doi:10.1097/00005792-200209000-00002 · Cited by 455
Risk of COVID‐19 for patients with obesity
Kassir, R. (2020) · Obesity Reviews · doi:10.1111/obr.13034 · Cited by 423
Panacek, E. A., Marshall, J. C., Albertson, T. E., Johnson, D. H., Johnson, S., MacArthur, R. D., Miller, M., Barchuk, W. T., Fischkoff, S., Kaul, M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145229.59014.6c · Cited by 387
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.010 · Cited by 384
Inflammatory pathways in female reproductive health and disease
Jabbour, H. N., Sales, K. J., Catalano, R. D., & Norman, J. E. (2009) · Reproduction · doi:10.1530/rep-09-0247 · Cited by 367
Rempel, S. A., Dudas, S., Ge, S., & Gutierrez, J. A. (2000) · PubMed · Cited by 364
Flier, J., Boorsma, D. M., van Beek, P. J., Nieboer, C., Stoof, T. J., Willemze, R., & Tensen, C. P. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200108)194:4<397::aid-path899>3.0.co;2-s · Cited by 363
Interleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
Flesch, I. E., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., & Kaufmann, S. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1615 · Cited by 345
Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G., & Sarfati, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1319 · Cited by 344
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
Czaja, A. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2515 · Cited by 342
Buchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 332
Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation
Ogrunc, M., Di Micco, R., Liontos, M., Bombardelli, L., Mione, M., Fumagalli, M., Gorgoulis, V. G., & d'Adda di Fagagna, F. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.16 · Cited by 328
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol
Condos, R., Rom, W. N., & Schluger, N. W. (1997) · The Lancet · doi:10.1016/s0140-6736(96)12273-x · Cited by 316
Arachidonic acid in cell signaling
Piomelli, D. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90116-8 · Cited by 297
Interleukin-1 and inflammatory neurodegeneration
Simi, A., Tsakiri, N., Wang, P., & Rothwell, N. J. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351122 · Cited by 288
Zhao, M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105982 · Cited by 274
The molecular action of tumor necrosis factor‐α
CAMUSSI, G., ALBANO, E., TETTA, C., & BUSSOLINO, F. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16337.x · Cited by 271
Transforming growth factor beta signal transduction.
Dennler, S., Goumans, M., & ten Dijke, P. (2002) · PubMed · Cited by 269
Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics
Chokkalingam, V., Tel, J., Wimmers, F., Liu, X., Semenov, S., Thiele, J., Figdor, C. G., & Huck, W. T. S. (2013) · Lab on a Chip · doi:10.1039/c3lc50945a · Cited by 252
Changes of the cytokine profile in inflammatory bowel diseases
Műzes, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5848 · Cited by 250
Pope, S. M., Zimmermann, N., Stringer, K. F., Karow, M. L., & Rothenberg, M. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5341 · Cited by 250
Modularity in the TNF-receptor family
Naismith, J. H., & Sprang, S. R. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01164-x · Cited by 248
Vlahopoulos, S., Boldogh, I., Casola, A., & Brasier, A. R. (1999) · Blood · doi:10.1182/blood.v94.6.1878 · Cited by 244
Fabbri, E., An, Y., Zoli, M., Simonsick, E. M., Guralnik, J. M., Bandinelli, S., Boyd, C. M., & Ferrucci, L. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu127 · Cited by 240
Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses
Chertov, O., Yang, D., Howard, O. M. Z., & Oppenheim, J. J. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17702.x · Cited by 216
Yuan, J., Zou, R., Zeng, L., Kou, S., Lan, J., Li, X., Liang, Y., Ding, X., Tan, G., Tang, S., et al. (2020) · Inflammation Research · doi:10.1007/s00011-020-01342-0 · Cited by 210
Enhanced synthesis of neutrophil-activating peptide-I/interleukin-8 in active ulcerative colitis
Mahida, Y. R., Ceska, M., Effenberger, F., Kurlak, L., Lindley, I., & Hawkey, C. J. (1992) · Clinical Science · doi:10.1042/cs0820273 · Cited by 199
Transforming growth factor β signal transduction
Dennler, S., Goumans, M.-J., & ten Dijke, P. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.731 · Cited by 198
Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
Kim, E. S., Choe, P. G., Park, W. B., Oh, H. S., Kim, E. J., Nam, E. Y., Na, S. H., Kim, M., Song, K.-H., Bang, J. H., et al. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.11.1717 · Cited by 193
Cytokine Function:A Study in Biologic Diversity
Cohen, M. C., & Cohen, S. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.5.589 · Cited by 191
Wang, W., Liu, X., Wu, S., Chen, S., Li, Y., Nong, L., Lie, P., Huang, L., Cheng, L., Lin, Y., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa387 · Cited by 191
Morjaria, J. B., Chauhan, A. J., Babu, K. S., Polosa, R., Davies, D. E., & Holgate, S. T. (2008) · Thorax · doi:10.1136/thx.2007.086314 · Cited by 190
Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A
Kawaguchi, Y., Hara, M., & Wright, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4304 · Cited by 187
A TNF-induced gene expression program under oscillatory NF-κB control
Tian, B., Nowak, D. E., & Brasier, A. R. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-137 · Cited by 179
Structural comparisons among the short-chain helical cytokines
Rozwarski, D. A., Gronenborn, A. M., Clore, G. M., Bazan, J. F., Bohm, A., Wlodawer, A., Hatada, M., & Karplus, P. A. (1994) · Structure · doi:10.1016/s0969-2126(00)00018-6 · Cited by 164
Zhou, Y., Hong, Y., & Huang, H. (2016) · Kidney and Blood Pressure Research · doi:10.1159/000452591 · Cited by 158
Bost, K. L., Ramp, W. K., Nicholson, N. C., Bento, J. L., Marriott, I., & Hudson, M. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/315138 · Cited by 150
COVID-19: In the Eye of the Cytokine Storm
de la Rica, R., Borges-Sa, M., & González‐Freire, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.558898 · Cited by 145
Autoinflammatory Diseases: Clinical and Genetic Advances
Farasat, S., Aksentijevich, I., & Toro, J. R. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.392 · Cited by 143
Interleukin-6 in the pathogenesis of rheumatoid arthritis.
Park, J. Y., & Pillinger, M. H. (2007) · PubMed · Cited by 143
Crown, J., Jakubowski, A., Kemeny, N., Gordon, M., Gasparetto, C., Wong, G., Sheridan, C., Toner, G., Meisenberg, B., & Botet, J. (1991) · Blood · doi:10.1182/blood.v78.6.1420.1420 · Cited by 142
TRANSCRIPTIONAL REGULATION DURING B CELL DEVELOPMENT
Henderson, A., & Calame, K. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.163 · Cited by 137
Interleukin-6 and rheumatic diseases.
Lipsky, P. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1918 · Cited by 125
The molecular mechanisms of chronic inflammation development
Murakami, M., & Hirano, T. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00323 · Cited by 122
Role of the Innate Cytokine Storm Induced by the Influenza A Virus
Gu, Y., Hsu, A., Pang, Z., Pan, H., Zuo, X., Wang, G., Zheng, J., & Wang, F. (2019) · Viral Immunology · doi:10.1089/vim.2019.0032 · Cited by 119
Bektas, A., Schurman, S. H., Gonzalez-Freire, M., Dunn, C. A., Singh, A. K., Macian, F., Cuervo, A. M., Sen, R., & Ferrucci, L. (2019) · Aging · doi:10.18632/aging.102438 · Cited by 116 · cited 2×
“The phenomenon of “Immunosenescence” (Bektas et al., 2019) contributes a critical role within the age-associated severity of COVID-19.”
Hendrayani, S.-F., Al-Harbi, B., Al-Ansari, M. M., Silva, G., & Aboussekhra, A. (2106) · Oncotarget · doi:10.18632/oncotarget.9633 · Cited by 114
Knowledge and beliefs about cancer in a socioeconomically disadvantaged population
Loehrer, P. J., Greger, H. A., Weinberger, M., Musick, B. S., Miller, M. E., Nichols, C. R., Bryan, J., Higgs, D., & Brock, D. (1991) · Cancer · doi:10.1002/1097-0142(19911001)68:7<1520::aid-cncr2820680710>3.0.co;2-2 · Cited by 112
Current status and challenges of cytokine pharmacology
Zídek, Z., Anzenbacher, P., & Kmoníčková, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00206.x · Cited by 112
Anti-TNF Therapy, from Rationale to Standard of Care: What Lessons Has It Taught Us?
Feldmann, M., & Maini, R. N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1090051 · Cited by 106
Henríquez‐Olguín, C., Altamirano, F. J., Valladares-Ide, D., Lopez, J. R., Allen, P. D., & Jaimovich, E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.012 · Cited by 104
Structure–Activity Relationship of Terpenes with Anti‐Inflammatory Profile – A Systematic Review
Souza, M. T. D. S., Almeida, J. R. G. D. S., Araújo, A. A. D. S., Duarte, M. C., Gelain, D. P., Moreira, J. C. F., dos Santos, M. R. V., & Quintans‐Júnior, L. J. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12221 · Cited by 104
Current treatments for chronic hepatitis B virus infections
Zoulim, F., Lebossé, F., & Levrero, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.06.004 · Cited by 97
Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases
Savic, S., Dickie, L. J., Battellino, M., & McDermott, M. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834dd2d5 · Cited by 94
Macrophage–neutrophil interaction: A paradigm for chronic inflammation revisited
Lefkowitz, D. L., & Lefkowitz, S. S. (2001) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2001.01020.x · Cited by 90
ICU-acquired immunosuppression and the risk for secondary fungal infections
Monneret, G., Venet, F., Kullberg, B. J., & Netea, M. G. (2010) · Medical Mycology · doi:10.3109/13693786.2010.509744 · Cited by 90
Interleukin-2 does not cross the blood-brain barrier by a saturable transport system
Waguespack, P. J., Banks, W. A., & Kastin, A. J. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90005-1 · Cited by 86
Englaro, W., Bahadoran, P., Bertolotto, C., Buscà, R., Dérijard, B., Livolsi, A., Peyron, J., Ortonne, J. P., & Ballotti, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202446 · Cited by 86
Neurologic manifestations of the cryopyrin-associated periodic syndrome
Kitley, J., Lachmann, H. J., Pinto, A. A., & Ginsberg, L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d9ed69 · Cited by 83
Liu, Z., Wang, Y., Wang, Y., Ning, Q., Zhang, Y., Gong, C., Zhao, W., Jing, G., & Wang, Q. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.003 · Cited by 80
A PEGylated Fab′ Fragment against Tumor Necrosis Factor for the Treatment of Crohn Disease
Bourne, T., Fossati, G., & Nesbitt, A. M. (2008) · BioDrugs · doi:10.2165/00063030-200822050-00005 · Cited by 79
Su, H. C., Leite‐Morris, K. A., Braun, L., & Biron, C. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2717 · Cited by 79
Duque, J. S. R., Flores, R. L., Oliver, S. R., Pontello, A. M., Zaldivar, F. P., & Galassetti, P. R. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00243.x · Cited by 77
Cytokine–receptor interactions as drug targets
Schreiber, G., & Walter, M. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.165 · Cited by 70
Inhibition of Neuroinflammation in LPS-Activated Microglia by Cryptolepine
Olajide, O. A., Bhatia, H. S., de Oliveira, A. C. P., Wright, C. W., & Fiebich, B. L. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/459723 · Cited by 70
Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease
Schapira, A. H. V. (2009) · Neurology · doi:10.1212/wnl.0b013e3181990438 · Cited by 67
Portugal‐Cohen, M., Horev, L., Rüffer, C., Schlippe, G., Voss, W., Ma’or, Z., Oron, M., Soroka, Y., Frušić‐Zlotkin, M., Milner, Y., et al. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.12.009 · Cited by 57
Khan, M. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-77976-8_2 · Cited by 54
Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD
Dong, T., Santos, S. M. B., Yang, Z., Yang, S., & Kirkhus, N. E. (2019) · The Analyst · doi:10.1039/c9an01704f · Cited by 52
Sepsis and cytomegalovirus: foes or conspirators?
Mansfield, S. A., Grießl, M., Gutknecht, M. F., & Cook, C. H. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0407-0 · Cited by 48
Cytokine and Chemokine Gene Expression of IL‐1β Stimulated Equine Articular Chondrocytes
David, F., Farley, J., Huang, H., Lavoie, J., & Laverty, S. (2007) · Veterinary Surgery · doi:10.1111/j.1532-950x.2007.00253.x · Cited by 47
Bachanova, V., Perales, M.-A., & Abramson, J. S. (2020) · Blood Reviews · doi:10.1016/j.blre.2019.100640 · Cited by 46
Serum and urinary cytokine levels of SLE patients
Brúgós, B. C., Vincze, Z., Sipka, S., Szegedi, G. Y., & Zeher, M. (2012) · Die Pharmazie · doi:10.31083/ph.2012.1694 · Cited by 46
Carpenter, L. R., Moy, J. N., & Roebuck, K. A. (2002) · BMC Infectious Diseases · doi:10.1186/1471-2334-2-5 · Cited by 46
A trial of recombinant human interleukin‐1 in patients with severe refractory aplastic anaemia
Walsh, C., Liu, J. M., Anderson, S. M., Rossio, J. L., Nienhuis, A. W., & Young, N. S. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06408.x · Cited by 44
Immune response in bacterial and Candida sepsis
Patricio, P., Paiva, J. A., & Borrego, L. M. (2019) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00011 · Cited by 42
Lackie, J. M. (2010) · Oxford University Press eBooks · doi:10.1093/acref/9780199549351.001.0001 · Cited by 37
Inflammation to cancer: The molecular biology in the pancreas (Review)
Ling, S., Feng, T., Jia, K., Tian, Y., & LI, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.2003 · Cited by 37
Human and murine interleukin 1 possess sequence and structural similarities.
Auron, P. E., Rosenwasser, L. J., Matsushima, K., et al. (1985) · PubMed · Cited by 37
Ouaguia, L., Mrizak, D., Renaud, S., Moralès, O., & Delhem, N. (2014) · Mediators of Inflammation · doi:10.1155/2014/564296 · Cited by 36
Liu, Q., Zhao, J., Tan, R. X., Zhou, H., Lin, Z., Zheng, M., Romas, E., Xu, J., & Sims, N. A. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2014.938113 · Cited by 36
Potential of on-line micro-LC immunochemical detection in the bioanalysis of cytokines
Schenk, T., Irth, H., Marko‐Varga, G., Edholm, L. E., Tjaden, U. R., & van der Greef, J. (2001) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(01)00464-2 · Cited by 35
Bitencourt, C. S., Bessi, V. L., Huynh, D. N., Ménard, L., Lefebvre, J. S., Lévesque, T., Hamdan, L., Sohouhenou, F., Faccioli, L. H., Borgeat, P., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12118 · Cited by 34
Nanoparticle Reservoirs for Paper-Only Immunosensors
Alba-Patiño, A., Adrover-Jaume, C., & de la Rica, R. (2019) · ACS Sensors · doi:10.1021/acssensors.9b01937 · Cited by 34
Possible Therapeutic Use of Natural Compounds Against COVID-19
Khan, N., Chen, X., & Geiger, J. D. (2021) · Journal of Cellular Signaling · doi:10.33696/signaling.2.036 · Cited by 33
Genetic and structural determinants of virus neutralizing antibodies
Crowe, J. E., Suara, R. O., Brock, S. C., Kallewaard, N. L., House, F. S., & Weitkamp, J.-H. (2001) · Immunologic Research · doi:10.1385/ir:23:2-3:135 · Cited by 28
Hematopoietic Cytokines - on the Verge of Conquering Neurology
Tonges, L., M. Schlachetzki, J., Weishaupt, J., & Bahr, M. (2007) · Current Molecular Medicine · doi:10.2174/156652407780059186 · Cited by 27
Phillips, R. E. (2002) · Nature Immunology · doi:10.1038/ni1102-987 · Cited by 27
A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia
Lutz, J. A., Kulshrestha, M., Rogers, D. T., & Littleton, J. M. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.06.012 · Cited by 26
Wakita, T., Shintani, F., Yagi, G., Asai, M., & Nozawa, S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02346-0 · Cited by 25
New Pharmacologic Strategies for Acute Neuronal Injury
Luer, M. S., Rhoney, D. H., Hughes, M. A., & Hatton, J. (1996) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1996.tb03000.x · Cited by 24
Peçanha, L. M., Snapper, C. M., Lees, A., & Mond, J. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3427 · Cited by 23
New guidelines for diagnosis of Parkinson disease
Martı́, M. J., & TOLOSA, E. S. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.47 · Cited by 20
Mast cell biology : contemporary and emerging topics
Gilfillan, A. M., & Metcalfe, D. D. (2011) · doi:10.1007/978-1-4419-9533-9 · Cited by 14
Lutz, J. A., Carter, M., Fields, L., Barron, S., & Littleton, J. M. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12896 · Cited by 13
The Therapeutic Potential of Interleukin-1 and Tumor Necrosis Factor on Hematopoietic Stem Cells
Moreb, J. S., & Zucali, J. R. (1992) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199209051006 · Cited by 12
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Cited by
The Potential Health Benefits of Gallic Acid: Therapeutic and Food Applications
Hadidi, M., Liñán-Atero, R., Tarahi, M., Christodoulou, M. C., & Aghababaei, F. (2024) · Antioxidants · doi:10.3390/antiox13081001 · Cited by 263
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175
Sic, A., Cvetkovic, K., Manchanda, E., & Knezevic, N. N. (2024) · Diseases · doi:10.3390/diseases12090220 · Cited by 65
“This inflammation can worsen metabolic disorders and promote neurodegenerative processes, highlighting the interconnectedness of stress, immune function, and overall health [19].”
BackgroundBioactive Peptides from Microalgae and Cyanobacteria and Their Possible Mechanisms of Action
Chitthan, S. V., Rasheed, A. S., Muniyandi, M., Dhanasekaran, D., & Thajuddin, N. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10746-7 · Cited by 12
Metadata
- Authors
- Megha, K., Joseph, X., Akhil, V., & Mohanan, P.
- Venue
- Phytomedicine
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 91
- Pages
- 153712
- ISSN
- 0944-7113 (ISSN-L)
- OpenAlex
- W3193854565
- Cited by
- 355
- References
- 162
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.